既往健康隐球菌脑膜炎患者中的脑静脉窦血栓形成
该回顾性队列分析了2005年1月至2024年4月收治的89例免疫功能正常的隐球菌脑膜炎患者,脑静脉窦血栓形成发生率为5.6%(CI 1.9%-12.6%)。未发现已知易栓症基因致病性变异,但cPIIRS患者脑脊液细胞中44个血栓相关基因表达升高。MRI和MRV是有价值的诊断工具,神经系统感染本身可能增加血栓风险。
要点
- 免疫功能正常隐球菌脑膜炎患者CVST发生率为5.6%(CI 1.9%-12.6%)
- 推荐脑MRI和MRV作为CVST诊断工具
- 未发现已知易栓症基因致病性变异,感染本身可能促血栓
核心结论
- CVST是隐球菌脑膜炎可治疗的并发症,MRI和MRV是有价值的诊断工具。
- 未发现易栓症基因突变,提示神经系统感染本身促发血栓风险。
- 脑脊液基因表达模式可能作为CVST易感性生物标志物。
研究设计与样本
- 回顾性队列研究,纳入2005年1月至2024年4月收治的89例免疫功能正常、非HIV隐球菌脑膜炎患者。
- 分析CVST发生率、临床病程、神经影像和实验室数据,并进行易栓症相关基因遗传分析。
- 对cPIIRS诊断时采集的脑脊液细胞进行单细胞RNA测序以探索神经炎症中的血栓相关基因表达。
主要发现
- CVST发生于5.6%(CI 1.9%-12.6%)的隐球菌脑膜炎患者,与细菌性中枢神经系统感染发生率相当。
- 未鉴定出已知易栓症相关基因的致病性变异。
- 在一例cPIIRS患者中,44个既往与血栓形成相关的基因表达升高(定义为≥150单细胞测序reads)。
临床怎么用
- 对隐球菌脑膜炎患者应警惕CVST,脑MRI和MRV可作为诊断工具。
- 免疫功能正常患者出现神经症状时需考虑CVST可能。
- 脑脊液基因表达模式未来或可辅助识别CVST易感患者。
局限性
- 回顾性研究设计。
- 样本量有限(89例)。
- 基因表达发现仅基于一例cPIIRS患者。
- 未来需病例对照研究验证并发现CVST遗传风险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cerebral venous sinus thrombosis (CVST), though a recognized complication of cryptococcal meningitis (CM), has been rarely reported. This study investigates the clinical features of CVST in a retrospective cohort of previously healthy, non-HIV CM patients. METHODS: We reviewed medical records of 89 immunocompetent CM patients admitted between January 2005 and April 2024. CVST incidence, clinical course, neuroimaging, and laboratory data were analyzed. Genetic analysis was performed to detect thrombophilia-associated variants. To explore thrombosis-related gene expression during neuroinflammation, cerebrospinal fluid (CSF) cells collected at the time of cryptococcal post-infectious inflammatory response syndrome (cPIIRS) diagnosis were subjected to single-cell RNA sequencing. RESULTS: CVST occurred in 5.6% (CI 1.9%-12.6%) of CM patients, a rate comparable to bacterial CNS infections. No known pathogenic variants in known thrombophilia-associated genes were identified. However, 44 genes previously linked to thrombosis showed elevated expression-defined as ≥150 single-cell sequencing reads-in a cPIIRS patient. CONCLUSIONS: CVST is a potentially treatable complication of CM. MRI and MRV of the brain are valuable diagnostic tools. The absence of thrombophilia mutations suggests that neurologic infection itself contributes to thrombotic risk. Notably, CSF gene expression patterns may serve as biomarkers for CVST susceptibility. Future case-control studies may validate these findings and uncover genetic risk factors contributing to CVST.
引用
- Anjum SH, Hargarten J, Dulek B, et al. Cerebral Venous Thrombosis in Previously Healthy Patients with Cryptococcal Meningitis. J Infect Dis. 2026. PMID: 41443253. doi:10.1093/infdis/jiaf653
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。